Advertisement

Topics

Companies Related to "French Industry Welcomes Moves Speed Access Innovative Drugs" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:54 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "French Industry Welcomes Moves Speed Access Innovative Drugs" found in our extensive corporate database of over 50,000 company records.

Showing "French Industry Welcomes Moves Speed Access Innovative Drugs" Companies 1–25 of 11,000+

Relevant

CEFI Summit - Lawficom Editions

The publisher of the magazine "Décideurs", the leading monthly French magazine dedicated to Finance & Law strategies with a circulation of 15 000 copies each month The organizer of the "Trophées du Droit", the only Awards ceremony to congratulate the leading members of the French legal industry The organizer of the CEFI, a unique event to gather all the European leaders of the Private Equity ind...


XxPansion Networks

XxPansion Networks is your internet service provider in the new information age. We provide services from high speed internet access to your business or home to web development and design to computer repair and training. We would love to be your partner in achieving your technology needs. Finally, you can enjoy the Internet the way it was meant to be with XxPansion Networks new High Speed Internet...

Normandie Développement Rouen

An Internationally Renowned French and European Region! 3.2 million inhabitants, 5th biggest French economic region, 2nd largest region for industrial investments per capita, Number one French port complex on the Channel seaboard, only 2 hours from Paris, 3 major employment areas: Rouen (725,000 inhab.), Le Havre (360,000 inhab.) and Caen-Bayeux (485,000 inhab.), World renowned tourist landmarks ...


Arminco

ARMINCO has been at the forefront of the Internet evolution and is a leading Internet service provider (ISP) in Armenia today, giving individuals and small businesses the ability to use the Internet as a medium to make their lives more productive and their businesses more profitable. ARMINCO is continually developing new and innovative services that make it a faster, easier and smarter Internet ex...

BIOCAD

Based in St. Petersburg, Russia, joint-stock company BIOCAD is a leading Russian private biopharmaceutical company, specializing in the research, development and manufacture of generic, biosimilar, and innovative drugs. BIOCAD works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to ...

The CIDER SANTE Group's

The CIDER SANTE Group's business is global externalization of services of the Pharmaceutical Industry in France, in French speaking African countries and in French overseas. Over the last 30 years, we have developed a group of complementary activities that aim to resume all or part of the development of a medical ethic or TBT among our clients, pharmaceutical laboratories, all this, on their behal...

CAYLA S.A.S.

Founded in 1977 by French scientists, CAYLA is an independant company aiming at exploiting its scientific and technical know-how through the design and development of innovative products and processes in molecular biology and microbial fermentation. At the start, CAYLA was specialized in the development of fermentation processes and the screening/improvement of microbial strains. CAYLA's innovativ...

Bosnalijek

Bosnalijek, Pharmaceutical and Chemical Industry, has been in the business of drug manufacturing and marketing for 55 years. The company was established in Sarajevo in 1951. Today, Bosnalijek is a joint stock company and one of the most stable and successful companies in Bosnia and Herzegovina. The production pipeline of Bosnalijek consists of: ethical drugs, drugs for self-medication, disinfectin...

Ys Therapeutics Co., Ltd

Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs.Our mission is to improve QOL (quality of life) for patients, their families and friends by developing innovative drugs.goal is to become an unchallenged citizen in the worldwide bio industry

DCB

The Development Center for Biotechnology (DCB) is an autonomous, non-profit research and development organization partially supported by the Government of the Republic of China on a contract basis. Established in March 1984, its purpose is to promote and upgrade the biotechnology industry in Taiwan. By linking with government, academic, and industrial sectors, the DCB develops key technologies, bu...

Biotech Communication SARL

Biotech Communication SARL - a limited company based north of Paris, France - offers a range of language and business development services to innovative biomedical, biotechnology, pharmaceutical and related service companies dealing with French-speaking clients or seeking to start/develop their business in France.These services include:English-French/French-English translation of technical and com...

Kendle International Inc.

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As on...

OSEO

OSEO group was born in 2005, by bringing together ANVAR (French innovation agency) and BDPME (SME development bank), around a mission of general interest supporting the regional and national policies. Its mission is to provide assistance and financial support to French SMEs and VSEs in the most decisive phases of their life cycle : start up, innovation, development, business transfer / buy out. By...

France Biotech

France Biotech is the French biotechnology association and the industry representative. Its mission is to contribute to position France and Europe as leaders in the Life sciences industry. France Biotech is acting on the four key factors of success for a strong biotechnology industry: • improving the academic R&D dynamics and funding: France Biotech supported the Strategic Council for Innovation...

Adamed Sp. z o.o.

Our priority is production of ethical drugs. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology and treatment of urinal tract infections.We invest in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our time, diabetes, venous thromboembolism (VT...

Global Internet Services

Privately held since 1996, Global Internet Services is the Internet Service Provider (ISP) for service and value-oriented individuals and businesses. Headquartered in San Diego, Global Internet Services has earned the reputation for long-lasting dedicated service relationships and continuous quality assurance. Global Internet Services provides high-quality connectivity, access availability and net...

Biologist Network

Each registered (french speaking) user in the directory has its own profile (for an example, click here). The user can access his profile at any time to modify it (or even to delete it). Each profile is also directly accessible via a web link. This web link can be use in the signature of an email.

Invest in France Agency

The Invest in France Agency is the French government agency for international investment. Our mission is to help our clients find the most profitable and competitive solution for their business in Europe.Invest in France Agency North America (IFANA) provides U.S., Canadian and Mexican executives with customized, confidential, complimentary services and information. In addition to access to financi...

ATLAB Pharma SAS

ATLAB Pharma SAS is a French biotechnology company based in Nantes. ATLAB is developing a pipeline of targeted anti-cancer drugs including antibodies, Lutetium-177 beta-emitting radiopharmaceuticals, and astatine-211 alpha-emitting radiopharmaceuticals.

Jean Boulle Group

The Jean Boulle Group Medical Division invests in promising medical technologies with funding and gives corporate and technical support. It welcomes queries.

The Henri A. Termeer Tribute Committee

Henri A. Termeer was a former Chairman, President and CEO of Genzyme Corporation for nearly three decades prior to its acquisition by the French drug maker Sanofi. Henri unexpectedly passed away on May 12, 2017 at the age of 71. He was known for his service to the rare disease community and his unsurpassed entrepreneurial leadership that spurred the rise o...

Value of Medical Innovation

The mission of the Value of Medical Innovation initiative (VOI) (www.valueofinnovation.org) is to demonstrate how medical progress and, specifically, innovative cancer therapies have made health care and longer life affordable and accessible. We do this through original research, a rich understanding of health care economics, outreach activities and social media....

Aveksa, Inc.

Aveksa provides the industry’s most comprehensive Business-Driven Identity and Access Management platform. By uniquely integrating Identity and Access Governance, Provisioning and Authentication, Aveksa enables enterprises to manage the complete lifecycle of user access for SaaS and On-premise applications and data. With Aveksa, IT organizations can r...

AMATSIGROUP

AMATSIGROUP, as a CDMO (Contract Development and Manufacturing Organisation), provides services throughout both preclinical and clinical phases in veterinary and human drugs. AMATSIGROUP, founded in 2010, was formed by the integration of four companies (Avogadro, Amatsi, DBI and Avepharm) bringing complementary expertise. With the reinforcement of more tha...

MEDEC

MEDEC is the national association created by and for the Canadian medical device industry. MEDEC is the primary source for advocacy, information and education on the medical device industry for members, the greater healthcare community, industry partners and the general public. Our goals are to advance health outcomes for patients in Canada and the growth and vibrancy of the industry in Canada. We...


More From BioPortfolio on "French Industry Welcomes Moves Speed Access Innovative Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks